Babylon (NYSE:BBLN) PT Lowered to $10.00

Babylon (NYSE:BBLNGet Rating) had its target price lowered by equities research analysts at BTIG Research from $15.00 to $10.00 in a report issued on Monday, The Fly reports. BTIG Research’s price objective would suggest a potential upside of 418.13% from the stock’s previous close.

BBLN has been the subject of a number of other reports. Zacks Investment Research raised Babylon from a “sell” rating to a “hold” rating in a research note on Monday, April 18th. Canaccord Genuity Group reduced their price target on Babylon from $14.00 to $8.00 and set a “buy” rating for the company in a research report on Friday, March 11th. Finally, Deutsche Bank Aktiengesellschaft initiated coverage on Babylon in a research report on Wednesday, January 12th. They issued a “buy” rating and a $9.00 price target for the company. Three analysts have rated the stock with a hold rating and four have issued a buy rating to the company’s stock. According to data from MarketBeat, the stock presently has a consensus rating of “Buy” and a consensus target price of $9.67.

Shares of Babylon stock opened at $1.93 on Monday. The company’s 50 day moving average price is $4.27. Babylon has a 12 month low of $1.75 and a 12 month high of $16.00. The company has a debt-to-equity ratio of 1.02, a current ratio of 2.37 and a quick ratio of 2.37.

A number of hedge funds have recently bought and sold shares of BBLN. Wells Fargo & Company MN purchased a new position in Babylon during the 4th quarter valued at about $58,000. Mirabella Financial Services LLP purchased a new position in shares of Babylon in the 4th quarter valued at about $63,000. JPMorgan Chase & Co. purchased a new position in shares of Babylon in the 4th quarter valued at about $63,000. Goldman Sachs Group Inc. purchased a new position in shares of Babylon in the 4th quarter valued at about $66,000. Finally, Penserra Capital Management LLC purchased a new stake in Babylon during the fourth quarter worth approximately $137,000. 62.45% of the stock is owned by institutional investors.

Babylon Company Profile (Get Rating)

Babylon Holdings Limited operates as a digital healthcare company. The company provides assistance to navigate the health system by connecting patients digitally to the clinicians. It operates in the United Kingdom, the United States, the Asia Pacific, Canada, and internationally. The company was founded in 2013 and is headquartered in London, the United Kingdom.

See Also

The Fly logo

Analyst Recommendations for Babylon (NYSE:BBLN)

Receive News & Ratings for Babylon Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Babylon and related companies with's FREE daily email newsletter.